Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T12797 Target Info
Target Name Bcl-2-related protein A1 (BCL2A1)
Synonyms Protein GRS; Protein BFL-1; Hemopoietic-specific early response protein; HBPA1; GRS; Bcl2-L-5; Bcl-2-like protein 5; BFL1; BCL2L5
Target Type Patented-recorded Target
Gene Name BCL2A1
UniProt ID
B2LA1_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
United States Patent and Trademark Office (USPTO)
Patent ID US8937193
Title Apogossypolone derivatives as anticancer agents
Abstract The disclosure provides compounds and methods of using Apogossypolone derivatives for treating diseases and disorders. In particular, the disclosure provides compounds of Formula I: or a pharmaceutically acceptable salt, hydrate, or solvate thereof, and provides methods for the preparation of compounds of Formula I; and methods for treating cancer, autoimmune diseases, and inflammation by administering a compound of Formula I.
Applicant(s) Sanford-Burnham Medical Research Institute
Representative Drug(s) D03TTE Drug Info N.A. Click to Show More [1]
2 D0B1UL Drug Info N.A. [1]
3 D0CR9A Drug Info N.A. [1]
Patent ID US8937193
Title Apogossypolone derivatives as anticancer agents
Abstract The disclosure provides compounds and methods of using Apogossypolone derivatives for treating diseases and disorders. In particular, the disclosure provides compounds of Formula I: or a pharmaceutically acceptable salt, hydrate, or solvate thereof, and provides methods for the preparation of compounds of Formula I; and methods for treating cancer, autoimmune diseases, and inflammation by administering a compound of Formula I.
Applicant(s) Sanford-Burnham Medical Research Institute
Representative Drug(s) D03TTE Drug Info N.A. Click to Show More [1]
2 D0B1UL Drug Info N.A. [1]
3 D0CR9A Drug Info N.A. [1]
Patent ID US8937193
Title Apogossypolone derivatives as anticancer agents
Abstract The disclosure provides compounds and methods of using Apogossypolone derivatives for treating diseases and disorders. In particular, the disclosure provides compounds of Formula I: or a pharmaceutically acceptable salt, hydrate, or solvate thereof, and provides methods for the preparation of compounds of Formula I; and methods for treating cancer, autoimmune diseases, and inflammation by administering a compound of Formula I.
Applicant(s) Sanford-Burnham Medical Research Institute
Representative Drug(s) D03TTE Drug Info N.A. Click to Show More [1]
2 D0B1UL Drug Info N.A. [1]
3 D0CR9A Drug Info N.A. [1]
References  Top
REF 1 Apogossypolone derivatives as anticancer agents. US8937193.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.